SLAMF9 antibody is predicted to not cross-react with other SLAM protein family members.
Purification
SLAMF9 Antibody is affinity chromatography purified via peptide column.
Immunogen
SLAMF9 antibody was raised against a 19 amino acid synthetic peptide near the carboxy terminus of human SLAMF9. The immunogen is located within the last 50 amino acids of SLAMF9.
SLAMF9
Reactivity: Human
WB, EIA
Host: Rabbit
Polyclonal
unconjugated
Application Notes
SLAMF9 antibody can be used for detection of SLAMF9 by Western blot at 1 - 2 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.
Antibody validated: Western Blot in mouse samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
SLAMF9 Antibody is supplied in PBS containing 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,4 °C
Storage Comment
SLAMF9 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
CD2F-10 antibody, CD2F10 antibody, CD84-H1 antibody, CD84H1 antibody, SF2001 antibody, 2310026I04Rik antibody, AI462096 antibody, Cd2f10 antibody, SLAM family member 9 antibody, SLAMF9 antibody, Slamf9 antibody
Background
SLAMF9 Antibody: The SLAM (signalling lymphocyte activation molecule) family is a novel group of receptors on T cells in modulating the immune response. SLAMF9, also known as CD2F-10 or CD84 homolog, is a 289 amino acid type I transmembrane protein that shares 58 % identity with the mouse protein. The SLAMF9 protein is predominantly expressed in hematopoietic tissues and contains an extracellular region with only two N-linked glycosylation sites, a 20-residue transmembrane region and a highly positively charged 30-residue cytoplasmic tail, suggesting a role for SLAMF9 as an adhesion molecule. SLAMF9 is thought to function in the immune response as a coreceptor for lymphocyte activation.